p110α RNAi inhibited growth and promoted apoptosis in all tested estrogen receptor positive (ER+) breast cancer cells under estrogen-deprived conditions, whereas p110β RNAi only affected cells harboring PIK3CB amplification. The gene discussed is PIK3CB; the disease is breast cancer.